VENABLE LLP for ENDO PHARMACEUTICALS INC
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Oversight of implementation of the American Invents Act. Issues relating to patent settlements. Legislation relating to abusive patent litigation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM R NORDWIND | — |
| ROBERT L SMITH | — |
Health Issues HCR
Issues relating to bioequivalence and related administrative procedures. Issues relating to prescription drug abuse. Issues relating to incentives for tamper-resistant formulations. H.R. 486 - Stop Tampering of Prescription Pills Act of 2013. Issues relating to Medicare Part D rebates. Issues relating to health information technology. H.R. 1919 - Safeguarding Americas Pharmaceuticals Act of 2013.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM R NORDWIND | — |
| ROBERT L SMITH | — |
Taxation/Internal Revenue Code TAX
Issues relating to incentives for life sciences research. H.R. 523/S. 232 - Protect Medical Innovation Act of 2013.
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM R NORDWIND | — |
| ROBERT L SMITH | — |
Pharmacy PHA
Issues related to tamper resistant formulation of pharmaceutical drugs. The Life Sciences Jobs and Investment Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| WILLIAM R NORDWIND | — |
| ROBERT L SMITH | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.